What is an IIT?

What makes an investigator-initiated trial different, and why can it be such an important opportunity for physicians? In Part 1 of this four-part Eyeprentice Learning Series, Nicole Fram, MD, discusses the role of the investigator and what it means to take ownership of a study. The investigator develops the clinical question, designs the study, oversees how the data are collected, and maintains responsibility for the results and publication. Industry support can still play an important role by providing funding, resources, mentorship, and access to experts such as statisticians or regulatory teams. The difference is that the investigator remains in control of the science and is able to pursue questions that may not be addressed in a traditional FDA trial. For physicians who see an unanswered question in their own practice, investigator-initiated research can help generate evidence that is meaningful to everyday patient care and valuable to colleagues across the field. To hear her full talk and view the complete Eyeprentice Learning Series, visit: https://www.eyeprentice.com/learning-series This independent series is presented by Eyeprentice with support from Alcon.